Drug Discovery · Allschwil, Switzerland · Founded 2019 · Privately Held (backing)
Operator of a clinical-stage biopharmaceutical company intended to offer various treatments for cancer and fibrotic diseases. Alentis Therapeutics is based in Allschwil, Switzerland and was founded in 2019. It has raised $362 million across 2 recorded rounds; the latest was an $181 million Series D in Nov 2024.
Last price · $/share
—
Implied valuation
—
Total raised
$362.5M
Last round
Later Stage VC (Series D)
Nov 2024
Team — not yet on record
No current team members for Alentis Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alentis Therapeutics with a free account
·The complete investor list: 21 names
·Watch Alentis Therapeutics: the Monday email on marks, rounds and moves
